Back to search

University of Southampton

Investigating cellular origins to identify peptide vaccine targets in two independent transmissible tumours circulating in the Tasmanian devil (Sarcophilus harrisii)

Abstract

dc:description.abstract

The Tasmanian devil (Sarcophilus harrisii) is under threat from two independent lineages of contagious cancer; Devil Facial Tumour 1 (DFT1) and Devil Facial Tumour 2 (DFT2), which are spread as allografts by biting and cause large tumours around the oral cavity of the animals. DFT1 is a Schwann cell derived tumour first identified in 1996 which persists in most wild devil populations, carrying a near 100% mortality and causing extreme population declines. DFT2 was identified in 2014 and is confined to a peninsula in the South-east of Tasmania, where its impact on devil populations has not yet been established. Despite indistinguishable gross phenotypes, evidence indicates that the tumours emerged independently in different animals. While DFT1 affected population declines have stabilised, DFT2 may be evolving to become a more widespread tumour, and further population declines threaten the future of the species. This project is part of a larger study to identify candidate vaccine targets in DFT1 and DFT2. DFT1 evades immune detection by downregulating Major Histocompatibility Complex (MHC) class I, but expression can be restored with interferon gamma (IFNγ) and the presence of MHC class I on DFT1 cells increases their immunogenicity. In contrast, DFT2 cells maintain expression of MHC class I. We postulate that a vaccine against MHC class I restricted peptides could induce specific immune responses against both tumours. To identify potential tumour specific vaccine targets it is necessary to characterise and compare the peptides bound by MHC class I on tumour cells to those presented on healthy progenitor cells and other devil tissues. Currently, nothing is known about the binding properties of Tasmanian devil MHC class I molecules and the progenitor cells of DFT1 and DFT2 lack specific definition. In this thesis I aim to identify the cellular origins of DFT2 and define the peptide binding motif of a biologically significant MHC class I allele in order to identify specific vaccine targets. Using a proteomics approach, I have demonstrated that DFT2 expresses proteins and genes specific to myelinating glial cells, indicating a similar origin to DFT1. However, DFT2 expresses lower levels of myelin associated proteins than DFT1 and shows an enrichment for developmental glial markers. These data indicate that DFT2 has emerged from an immature myelinating glial cell, whilst DFT1 emerged from a myelinating or pro-myelinating Schwann cell. Additionally, using immunohistochemical techniques I have demonstrated that the MHC class I expression profile of Schwann cells is potentially immune evasive, making these cells prone to transmissible malignant transformation. I also show that like DFT1, DFT2 upregulates MHC class I in response to IFNγ, but demonstrates a transcriptional response that is indicative of an oligodendroglial origin, and a distinct immunosuppressive gene expression profile which is largely unaffected by IFNγ. I have generated a DFT2 cell line overexpressing a recombinant MHC class I allele which is present in the genomes of DFT1 and DFT2 and common in the wider devil population. This is, to our knowledge, the first stable transfection of DFT2 cells and these cell lines and experimental pipelines can be used for further study of the antigen presentation pathway in the Tasmanian devil and other non-model species. These data have indicated unusual properties of MHC class I peptide binding in the Tasmanian devil which were previously unknown. Perhaps most importantly, the data generated in this thesis indicates that despite their independent origins, DFT1 and DFT2 may share neoantigens, thus these tumours may respond to a single vaccination strategy, a finding with significant scientific and economic interest for the DFT vaccination programme.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Southampton
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Owen, Rachel Siân
Advisors dc:contributor.advisor
  • Siddle, Hannah
  • Skipp, Paul
ORCID person:identifier.orcid

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Owen, Rachel Siân. Investigating cellular origins to identify peptide vaccine targets in two independent transmissible tumours circulating in the Tasmanian devil (Sarcophilus harrisii). doctoral thesis, University of Southampton, 2019.